Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 2 Lymphoma, Follicular 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 4 aflutinib 3 Saline Solution 3 Radiosurgery 3 pembrolizumab 2 Temozolomide 2 Receptors, Interleukin-8B 2 Pemetrexed 2 Memantine 2 Magnetic Resonance Spectroscopy 2 Indocyanine Green 2 Dexmedetomidine 2 Cyclophosphamide 2 Carboplatin 2 Blood Specimen Collection 2 Bevacizumab 2 vorasidenib 1 urinastatin 1 trastuzumab deruxtecan 1 tovorafenib 1 sacituzumab govitecan 1 posaconazole 1 peginterferon alfa-2b 1 osimertinib 1 neratinib 1 montelukast 1 gallium maltolate 1 fludarabine 1 dalpiciclib 1 asciminib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Brain Neoplasms × vorasidenib × Clear all

NCT07629089 2026-06-05

VALIENT

University of Pittsburgh

Phase 1 Not yet recruiting

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡